Ehrlich Christopher B
Insider CIK 1293973 · BMTI Director · TSPT Director, 10% owner · TSRO 10% owner · LWAC See Remarks, Director · PBAX Interim Chairman and CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2026-01-07 | 2026-01-09 | 4,530,997 | — | $0 | 4,530,997 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-05-30 | 2025-06-02 | 61,843 | — | $0 | 61,842 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-03-04 | 2025-03-06 | 119,486 | — | $0 | 119,486 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-02-24 | 2025-02-26 | 1,275,000 | — | $0 | 2,550,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-12-02 | 2024-12-04 | 1,275,000 | — | $0 | 1,275,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | D To issuer deriv | 2024-09-30 | 2024-10-02 | 572,182 | — | $0 | 0 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | M Exercise deriv | 2024-09-25 | 2024-10-02 | 275 | $1000.00 | $275.0K | 0 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | M Exercise | 2024-09-25 | 2024-10-02 | 5,312,983 | — | $0 | 5,791,808 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-06-13 | 2024-06-13 | 800 | — | $0 | 800 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-03-25 | 2024-03-27 | 572,182 | — | $0 | 572,182 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-02-19 | 2024-02-21 | 2,000 | — | $0 | 2,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-02-14 | 2024-02-16 | 100 | $1000.00 | $100.0K | 100 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | M Exercise deriv | 2024-02-14 | 2024-02-16 | 0 | — | $0 | 0 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | M Exercise deriv | 2024-02-14 | 2024-02-16 | 1,555 | $1000.00 | $1.55M | 1,555 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other deriv | 2024-02-14 | 2024-02-16 | 1,555 | $1000.00 | $1.55M | 0 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other deriv | 2024-02-14 | 2024-02-16 | 175 | $1000.00 | $175.0K | 275 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other deriv | 2024-02-14 | 2024-02-16 | 349,998 | — | $0 | 0 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other deriv | 2024-02-14 | 2024-02-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-16 | 3,600 | — | $0 | 3,600 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-16 | 478,825 | — | $0 | 478,825 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-16 | 4,171,246 | — | $0 | 1,000,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-16 | 1,125,000 | — | $0 | 4,171,246 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-06-22 | 2023-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-01-20 | 2023-01-24 | 35,938 | — | $0 | 35,938 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-10-04 | 2022-10-06 | 346 | $0.57 | $197 | 35,213 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-09-26 | 2022-09-27 | 18,867 | $0.55 | $10.4K | 34,867 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-06-09 | 2022-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-02-18 | 2022-02-22 | 1,000 | $4.30 | $4.3K | 16,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-02-14 | 2022-02-22 | 2,000 | $4.45 | $8.9K | 15,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-02-09 | 2022-02-10 | 1,000 | $4.75 | $4.8K | 13,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-02-08 | 2022-02-10 | 1,000 | $4.92 | $4.9K | 12,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-02-04 | 2022-02-07 | 1,000 | $5.00 | $5.0K | 11,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-02-03 | 2022-02-07 | 5,000 | $5.15 | $25.8K | 10,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-01-27 | 2022-01-31 | 5,000 | $5.30 | $26.5K | 5,000 | SEC↗ |
| PBAX PHOENIX BIOTECH ACQUISITIO | J Other deriv | 2021-10-08 | 2021-10-12 | 18,366 | — | $0 | 349,998 | SEC↗ |
| PBAX PHOENIX BIOTECH ACQUISITIO | J Other deriv | 2021-10-08 | 2021-10-12 | 82,875 | — | $0 | 4,596,250 | SEC↗ |
| PBAX PHOENIX BIOTECH ACQUISITIO | J Other | 2021-10-08 | 2021-10-12 | 36,733 | $10.00 | $367.3K | 699,996 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-10-06 | 2021-10-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | C Conversion deriv | 2021-08-25 | 2021-08-27 | 142,168 | — | $0 | 0 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | D To issuer deriv | 2021-08-25 | 2021-08-27 | 132,832 | — | $0 | 142,168 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | D To issuer deriv | 2021-08-25 | 2021-08-27 | 966 | — | $0 | 1,034 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | C Conversion deriv | 2021-08-25 | 2021-08-27 | 1,034 | — | $0 | 0 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | C Conversion | 2021-08-25 | 2021-08-27 | 1,034 | — | $0 | 1,034 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | C Conversion | 2021-08-25 | 2021-08-27 | 142,168 | — | $0 | 142,168 | SEC↗ |
| LWAC Locust Walk Acquisition Co | J Other deriv | 2021-01-12 | 2021-01-14 | 23,750 | — | $0 | 4,511,250 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2013-04-10 | 2013-04-11 | 13,500 | — | $0 | 13,500 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | D To issuer deriv | 2013-03-01 | 2013-03-05 | 5,831 | — | $0 | 0 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | D To issuer deriv | 2013-03-01 | 2013-03-05 | 8,840 | — | $0 | 0 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | D To issuer | 2013-03-01 | 2013-03-05 | 6,846 | — | $0 | 0 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | D To issuer | 2013-03-01 | 2013-03-05 | 857,692 | — | $0 | 0 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | D To issuer | 2013-03-01 | 2013-03-05 | 24,538 | — | $0 | 0 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | D To issuer | 2013-03-01 | 2013-03-05 | 1,250 | — | $0 | 0 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | D To issuer | 2013-03-01 | 2013-03-05 | 941,177 | — | $0 | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2013-01-07 | 2013-01-08 | 13,500 | — | $0 | 13,500 | SEC↗ |
| TSRO TESARO, Inc. | C Conversion deriv | 2012-07-03 | 2012-07-05 | 9,195,402 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | C Conversion | 2012-07-03 | 2012-07-05 | 2,627,257 | — | $0 | 2,627,257 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2012-07-03 | 2012-07-05 | 444,444 | $13.50 | $6.00M | 3,071,701 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2012-01-24 | 2012-01-25 | 7,000 | — | $0 | 7,000 | SEC↗ |